Deep Brain Stimulation

I know a couple of people who have had the DBS implanted. The individual with CP seemed to have gotten some good results. Others have had to have it removed due to infection. The individual with Parkinson’s ended up having a stroke because they forgot to give him an anti seizure medication before the procedure so for him, they didn’t get the results they hoped for. It was very sad and difficult for him and his family.

My child just finished a 3 week inpatient rehab stay about 2 weeks of being on neuro unit after her DBS implant procedure. It really increased her confidence and she regained some lost skills!

Dr. Michael Kruer discusses the use of Deep Brain Stimulation (DBS) for treating movement disorders in patients with cerebral palsy. He emphasizes that DBS aims to reduce unwanted muscle activations and improve quality of life, but it does not directly enhance a person's ability to move better. Collaboration between therapists, physicians, and medical providers is crucial for success. While DBS can sometimes improve posture and reduce pain, its effectiveness varies among patients. Dr. Kruer highlights the importance of shared decision-making and setting realistic expectations, as not all patients experience dramatic improvements.

Dr. Terence Sanger explains that deep brain stimulation (DBS) is a treatment that targets electrically active regions of the brain, affecting tens to hundreds of millions of cells. He notes that DBS is anatomically specific but impacts a broad area of brain tissue. For cerebral palsy, particularly secondary dystonia, DBS has shown potential but requires individualized targeting since no two children have the same brain deficits and strengths. Dr. Sanger emphasizes that earlier approaches to DBS were less effective because they assumed all children had the same problem, leading to suboptimal results. He advocates for a tailored approach, borrowing techniques from epilepsy surgery, to improve outcomes.

This study investigated the effects of deep brain stimulation (DBS) on quality of life in children with dyskinetic cerebral palsy who did not respond to medication. It was conducted as a prospective, single-arm, multicenter study, followed by a randomized double-blind crossover phase to compare active and sham stimulation.

The study found that after 12 months of DBS, there was a small improvement in quality of life scores (CPCHILD) and significant improvements in specific measures like the Canadian Occupational Performance Measure (COPM) and physical health component of the SF-36. However, the overall evidence was not strong enough to recommend DBS as a routine treatment for improving quality of life in these patients.

For families and caregivers of children with dyskinetic cerebral palsy, this study suggests that DBS might offer some benefits in specific areas like physical health and task performance. However, it also highlights that the treatment is not yet proven to significantly improve overall quality of life.

The study is fairly reliable as it was conducted across multiple centers and included a randomized double-blind phase, which reduces bias. However, the small sample size of 16 patients limits the generalizability of the findings, and further research with larger groups is needed.

This paper investigated the effects of deep brain stimulation (DBS) on individuals with dyskinetic cerebral palsy, a condition characterized by involuntary movements. The researchers conducted a meta-analysis of 20 studies involving 68 patients, using a specific scale called the Burke-Fahn-Marsden Dystonia Rating Scale to measure movement and disability outcomes before and after DBS treatment.

The study found that DBS led to a significant improvement in movement scores, with an average reduction of 23.6% in dystonia severity, and a smaller improvement in disability scores, with a 9.2% reduction. These improvements were observed at a median follow-up of 12 months, and the data also showed that patients with more severe dystonia tended to have less pronounced improvements.

For individuals with dyskinetic cerebral palsy, this study suggests that DBS could be a promising treatment option to reduce involuntary movements and improve quality of life. However, the variability in outcomes highlights the need for careful patient selection and management.

As a meta-analysis, this study provides a high level of evidence by combining data from multiple studies. However, the included studies were mostly case reports with varying follow-up durations, which introduces some limitations in the reliability of the findings.